Takeshi Terui
- Co-authors
- Paul A. RandazzoRichard KahnRishu TakimotoYoshiro NiitsuJunji KatoTakuya MatsunagaAnthony G. FerrigeHenry M. Fales
- Topics
- Chronic Myeloid Leukemia Treatments (3 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers)Acute Myeloid Leukemia Research (2 papers)
- Partner nations
- JapanUnited StatesRussia
In The Last Decade
Takeshi Terui
18 papers receiving 506 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 394
- Cell Biology 159
- Oncology 98
- Cancer Research 48
- Hematology 47
Countries citing papers authored by Takeshi Terui
This map shows the geographic impact of Takeshi Terui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Terui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Terui more than expected).
Fields of papers citing papers by Takeshi Terui
This network shows the impact of papers produced by Takeshi Terui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Terui. The network helps show where Takeshi Terui may publish in the future.
Co-authorship network of co-authors of Takeshi Terui
This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Terui. A scholar is included among the top collaborators of Takeshi Terui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Terui. Takeshi Terui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | [Reappearance of t(12;17)-positive primary myelofibrosis following Ph+ CML cell reduction by imatinib]. | 1 |
| 3 | 54 | |
| 4 | 7 | |
| 5 | [Second hematologic response and disappearance of the ABL gene mutant clone by cessation of imatinib in a CML patient with resistance to imatinib]. | 1 |
| 6 | 45 | |
| 7 | [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia]. | 1 |
| 8 | 14 | |
| 9 | Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity. | 71 |
| 10 | 9 | |
| 11 | Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors. | 96 |
| 12 | 1 | |
| 13 | [Successful treatment with G-CSF and corticosteroid of adult idiopathic autoimmune neutropenia presenting as recurrent enterocolitis]. | 1 |
| 14 | [Treatment of chronic myelogenous leukemia with imatinib mesylate resulting in hematological remission and marked regression of myelofibrosis]. | 1 |
| 15 | 10 | |
| 16 | 108 | |
| 17 | 74 | |
| 18 | Cloning and Expression of the Gene for Human Transforming Growth Factor-β in Escherichia Coli | 1 |
About Takeshi Terui
Takeshi Terui is a scholar working on Hematology, Physiology and Genetics, having authored 18 papers that have together received 517 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Physiology (46 citations), Cell Biology (159 citations) and Molecular Biology (394 citations). Takeshi Terui has collaborated with scholars based in Japan, United States and Russia. Frequent co-authors include Paul A. Randazzo, Richard Kahn, Rishu Takimoto, Yoshiro Niitsu, Junji Kato, Takuya Matsunaga, Anthony G. Ferrige, Henry M. Fales, Tetsuji Takayama and Masayoshi Kobune. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.